Gene: TNKS2
Official Full Name: tankyrase 2provided by HGNC
Gene Summary: Enables NAD+-protein poly-ADP-ribosyltransferase activity and enzyme binding activity. Involved in several processes, including positive regulation of canonical Wnt signaling pathway; post-translational protein modification; and regulation of telomere maintenance. Located in nuclear envelope; pericentriolar material; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25999 | TNKS2 Knockout cell line (HeLa) | Human | TNKS2 | 1:3~1:6 | Negative | Online Inquiry |
KO26000 | TNKS2 Knockout cell line (HCT 116) | Human | TNKS2 | 1:2~1:4 | Negative | Online Inquiry |
KO26001 | TNKS2 Knockout cell line (HEK293) | Human | TNKS2 | 1:3~1:6 | Negative | Online Inquiry |
KO26002 | TNKS2 Knockout cell line (A549) | Human | TNKS2 | 1:3~1:4 | Negative | Online Inquiry |
TNKS2 Gene Knockout Cell Lines are meticulously engineered cellular models designed to investigate the functional role of the TNKS2 (Tankyrase 2) gene in various biological processes. These gene knockout models have been constructed to provide researchers with an invaluable tool for understanding the molecular mechanisms underpinning cellular signaling, proliferation, and apoptosis. The disruption of TNKS2 activity has been shown to impact poly(ADP-ribose) polymerase (PARP) activity, influencing a range of intracellular pathways critical for cellular homeostasis.
These cell lines facilitate the study of TNKS2's involvement in important cellular functions, particularly its contribution to telomere maintenance and modulation of the Wnt signaling pathway. Through precise gene editing techniques, such as CRISPR/Cas9, the TNKS2 knockout cell lines eliminate the expression of this gene, allowing for in-depth analyses of its biological implications. As a result, these models are essential for elucidating the role of TNKS2 in cancer biology, regenerative medicine, and cellular aging.
The scientific importance of these cell lines extends to a wide array of research and clinical applications. They not only serve as a platform for drug discovery and therapeutic interventions but also act as vital tools for exploring genetic predispositions to diseases that involve TNKS2 dysregulation. Compared to traditional knockdown methodologies, our knockout cell lines provide stable, heritable changes that enable long-term study and reproducibility across experiments, thus enhancing experimental reliability.
Researchers and clinicians will find great value in adopting TNKS2 Gene Knockout Cell Lines due to their precise phenotype characterization and the robust data they generate. By utilizing these models, users can enhance their understanding of key cellular processes and accelerate the translation of findings into clinical applications.
This product is backed by our company’s extensive expertise in the development of advanced biological models and commitment to supporting scientific innovation. Our ongoing research and development ensure that we provide cutting-edge solutions tailored to the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.